Telyrx Holdings Inc. funding
Telyrx Holdings Inc., a pharmaceuticals company based in Toronto, Ontario, Canada (founded 2026), filed a Form D with the SEC on April 20, 2026 and reported $12.6M raised.
Amount raised$12.6M
Offering size$12.6M
Filed with the SECApril 20, 2026
First saleMarch 31, 2026
IndustryPharmaceuticals
SecuritiesEquity, Security to be acquired on exercise, Other
LocationToronto, Ontario, Canada
Founded2026
Entity typeCorporation
Investors so far51
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Apr 20
Other health care rounds
Lisata Therapeutics, Inc.$352M · Oct 2BiotechnologyPrecision Neuroscience Corp$250M · Sep 28Other Health CareZai Lab Ltd$250M · Nov 9BiotechnologyAmerican Republic Insurance Co.$95M · Oct 22Health InsuranceBridge To Life Ltd.$82.5M · Oct 21Other Health CareAlpfa Medical, Inc.$80.3M · Sep 28Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyTypewriter Therapeutics, Inc.$56.3M · Sep 21Biotechnology